173 related articles for article (PubMed ID: 33397384)
1. Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma.
Miao Y; Liu G; Liu L
Cancer Cell Int; 2021 Jan; 21(1):2. PubMed ID: 33397384
[TBL] [Abstract][Full Text] [Related]
2. Retraction Note: Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma.
Miao Y; Liu G; Liu L
Cancer Cell Int; 2023 Aug; 23(1):173. PubMed ID: 37596581
[No Abstract] [Full Text] [Related]
3. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells.
Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527
[TBL] [Abstract][Full Text] [Related]
4. Histone methyltransferase SUV39H2 serves oncogenic roles in osteosarcoma.
Piao L; Yuan X; Zhuang M; Qiu X; Xu X; Kong R; Liu Z
Oncol Rep; 2019 Jan; 41(1):325-332. PubMed ID: 30542727
[TBL] [Abstract][Full Text] [Related]
5. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
[TBL] [Abstract][Full Text] [Related]
6. Lysine-specific demethylase 1 induced epithelial-mesenchymal transition and promoted renal fibrosis through Jagged-1/Notch signaling pathway.
Zhang H; Xing J; Zhao L
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S203-S214. PubMed ID: 34396798
[TBL] [Abstract][Full Text] [Related]
7. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.
Lin T; Ponn A; Hu X; Law BK; Lu J
Oncogene; 2010 Sep; 29(35):4896-904. PubMed ID: 20562920
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of Variegation 3-9 Homolog 2, a Novel Binding Protein of Translationally Controlled Tumor Protein, Regulates Cancer Cell Proliferation.
Kim AR; Sung JY; Rho SB; Kim YN; Yoon K
Biomol Ther (Seoul); 2019 Mar; 27(2):231-239. PubMed ID: 30763986
[TBL] [Abstract][Full Text] [Related]
9. LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter.
Liu Y; Wang Y; Chen C; Zhang J; Qian W; Dong Y; Liu Z; Zhang X; Wang X; Zhang Z; Shi X; Wu S
Oncotarget; 2017 Feb; 8(7):11329-11342. PubMed ID: 27894088
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
[TBL] [Abstract][Full Text] [Related]
11. LSD1 silencing inhibits the proliferation, migration, invasion, and epithelial-to-mesenchymal transition of hypopharyngeal cancer cells by inducing autophagy and pyroptosis.
Wang H; Liu F
Chin J Physiol; 2023; 66(3):162-170. PubMed ID: 37322626
[TBL] [Abstract][Full Text] [Related]
12. Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells.
Chen J; Ding J; Wang Z; Zhu J; Wang X; Du J
Oncotarget; 2017 Mar; 8(12):19609-19630. PubMed ID: 28121627
[TBL] [Abstract][Full Text] [Related]
13. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-XIST promotes the oxidative stress-induced migration, invasion, and epithelial-to-mesenchymal transition of osteosarcoma cancer cells through miR-153-SNAI1 axis.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cell Biol Int; 2020 Oct; 44(10):1991-2001. PubMed ID: 32515520
[TBL] [Abstract][Full Text] [Related]
15. The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression.
Zhang J; Fan X; Zhou Y; Chen L; Rao H
J Exp Clin Cancer Res; 2022 Jun; 41(1):191. PubMed ID: 35655230
[TBL] [Abstract][Full Text] [Related]
16. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion.
Li Y; Wan X; Wei Y; Liu X; Lai W; Zhang L; Jin J; Wu C; Shao Q; Shao G; Lin Q
Oncol Rep; 2016 Jun; 35(6):3586-92. PubMed ID: 27109588
[TBL] [Abstract][Full Text] [Related]
17. N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.
Yang J; Xu P; Chen Z; Zhang X; Xia Y; Fang L; Xie L; Li B; Xu Z
Cancer Lett; 2023 Apr; 558():216092. PubMed ID: 36806557
[TBL] [Abstract][Full Text] [Related]
18. Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteins.
Piao L; Nakakido M; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2016 Apr; 7(16):22846-56. PubMed ID: 26988914
[TBL] [Abstract][Full Text] [Related]
19. Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma.
Zheng Y; Li B; Wang J; Xiong Y; Wang K; Qi Y; Sun H; Wu L; Yang L
Clin Epigenetics; 2018 Oct; 10(1):129. PubMed ID: 30348215
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis.
Alsaqer SF; Tashkandi MM; Kartha VK; Yang YT; Alkheriji Y; Salama A; Varelas X; Kukuruzinska M; Monti S; Bais MV
Oncotarget; 2017 Sep; 8(43):73372-73386. PubMed ID: 29088714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
